Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cell Design Labs

Cell Design Labs
2015 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
$567M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of cell-based disruptive therapies designed to offer treatment for cancer and other devastating diseases. The company's therapies include disruptive T cell receptor therapies that modifies the body's immune cells to create therapeutic agents capable of selectively recognizing, disabling and destroying malignant threats, enabling medical researchers to develop cell-based therapies efficiently.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Primary Office
  • 5858 Horton Street
  • Suite 240
  • Emeryville, CA 94608
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cell Design Labs’s full profile, request a free trial.

Cell Design Labs Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Dec-2017 $567M 000.00 00000 Completed Generating Revenue
4. Accelerator/Incubator 02-Feb-2017 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 16-Jun-2016 000 000.00 0000 Completed Generating Revenue
2. Early Stage VC (Series B) 21-Dec-2015 $22.9M $30.7M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) $7.8M $7.8M 000.00 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Cell Design Labs Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 0,000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 3,900,940 $0.000100 6% $2 $2 1x $2 24.12%
To view this company’s complete Cap Table, request access »

Cell Design Labs Competitors (57)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CytImmune Venture Capital-Backed Rockville, MD 000.00 0000000000 0 000.00
00000000 Venture Capital-Backed Tübingen, Germany 000 00000 00000000000 00000
00000000 Formerly VC-backed Munich, Germany 000.00 000000&0 000.00
0000000000 Venture Capital-Backed Abingdon, United Kingdom 000 00000 00000000000 00000
000000 Venture Capital-Backed Utrecht, Netherlands 00.000 00000000000 00.000
To view this company’s complete list of competitors, request access »

Cell Design Labs Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Arie Belldegrun Angel (individual) Minority 000 0000 000000 0
Brian Atwood Angel (individual) Minority 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator Minority 000 0000 000000 0
JLABS Accelerator/Incubator Minority 000 0000 000000 0
Kleiner Perkins Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Cell Design Labs Executive Team (6)

Name Title Board
Seat
Contact
Info
Peter Emtage Ph.D Chief Scientific Officer
Wendell Lim Ph.D Scientific Founder & Board Observer
Gregory Giotta Ph.D Senior Vice President Intellectual Property
Roger Sidhu MD Chief Medical Officer
Fred Cohen MD Chairman & Co-Founder

1 Former Executive

You’re viewing 5 of 6 executives. Get the full list »

Cell Design Labs Board Members (7)

Name Representing Role Since Contact
Info
Fred Cohen MD Self Chairman & Co-Founder 000 0000
Wendell Lim Ph.D Cell Design Labs Scientific Founder & Board Observer 000 0000

5 Former Board Members

You’re viewing 2 of 7 board members. Get the full list »